Literature DB >> 27106552

Timely tumor response analysis after preoperative chemoradiotherapy and curative surgery in locally advanced rectal cancer: A multi-institutional study for optimal surgical timing in rectal cancer.

Yoo-Kang Kwak1, Kyubo Kim2, Jong Hoon Lee3, Sung Hwan Kim1, Hyeon Min Cho1, Dae Yong Kim4, Tae Hyun Kim4, Sun Young Kim4, Ji Yeon Baek4, Jae Hwan Oh4, Taek Keun Nam5, Mee Sun Yoon5, Jae Uk Jeong5, Eui Kyu Chie6, Hong Seok Jang7, Jae Sung Kim8.   

Abstract

BACKGROUND AND
PURPOSE: The definite surgical timing in rectal cancer after preoperative chemoradiotherapy (CRT) has not yet been fully examined. We assess the tumor response and identify the optimal operation timing after preoperative CRT in rectal cancer. METHODS AND MATERIALS: The study included data of 1786 patients with locally advanced rectal cancer (cT3-4N0-2M0). They received preoperative CRT followed by total mesorectal excision. Total radiation dose was 50.4Gy in 28 fractions. Interval time between preoperative CRT and surgery ranged from 2 to 26weeks, with a median interval of 7.2weeks. Primary endpoint was to evaluate the period of highest downstaging and pathological complete response (ypCR) rates to determine the optimal timing for curative surgery after CRT.
RESULTS: Downstaging rates peaked between 6 and 7weeks after CRT and declined afterward. ypCR rates increased from 5 to 6weeks after CRT and decreased after 9 to 10weeks. Downstaging rates were similar between the two arms showing 36.9% in the early arm (⩽7weeks) and 37.0% in the delayed arm (>7weeks). ypCR rates were significantly higher in the delayed arm, as compared to the early arm (12.3% vs. 8.6%, p=0.011). The delayed arm had higher sphincter preservation rates than the early arm with a marginal significance (92.4% vs. 89.9%, p=0.078). There was no statistically significant difference regarding relapse-free survival and overall survival between the two arms.
CONCLUSIONS: ypCR rates increased after 5weeks and decreased after 10weeks and the delayed (>7weeks after CRT) group showed significantly increased ypCR rates than the early arm (⩽7weeks after CR). The optimal timing for curative surgery in rectal cancer when tumor response is maximal is after 7weeks and before 10weeks following preoperative CRT.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chemoradiotherapy; Rectal cancer; Response; Surgery; Timing

Mesh:

Year:  2016        PMID: 27106552     DOI: 10.1016/j.radonc.2016.03.017

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  14 in total

1.  [Time interval between neoadjuvant radiochemotherapy and surgery in rectal cancer : No impact on the pathologic complete response rate?]

Authors:  Cihan Gani; Daniel Zips
Journal:  Strahlenther Onkol       Date:  2017-01       Impact factor: 3.621

2.  Report from the 19th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Winnipeg, Manitoba; 29-30 September 2017.

Authors:  C A Kim; S Ahmed; S Ahmed; B Brunet; H Chalchal; R Deobald; C Doll; M P Dupre; V Gordon; R M Lee-Ying; H Lim; D Liu; J M Loree; J P McGhie; K Mulder; J Park; B Yip; R P Wong; A Zaidi
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

3.  Neoadjuvant chemoradiotherapy of the rectal carcinoma - The correlation between the findings on the restaging multiparametric 3T MRI scanning and the surgical findings.

Authors:  Radovan Vojtíšek; Eva Korčáková; Jan Mařan; Ondřej Šorejs; Jindřich Fínek
Journal:  Rep Pract Oncol Radiother       Date:  2017-05-05

Review 4.  Effect of pathological complete response after neoadjuvant chemoradiotherapy on postoperative complications of rectal cancer: a systematic review and meta-analysis.

Authors:  J Yang; W Wang; Y Luo; S Huang; Z Fu
Journal:  Tech Coloproctol       Date:  2022-01-20       Impact factor: 3.781

5.  Time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: A population study on 2094 patients.

Authors:  Gabriella Macchia; Maria Antonietta Gambacorta; Carlotta Masciocchi; Giuditta Chiloiro; Giovanna Mantello; Maika di Benedetto; Marco Lupattelli; Elisa Palazzari; Liliana Belgioia; Almalina Bacigalupo; Aldo Sainato; Sabrina Montrone; Lucia Turri; Angela Caroli; Antonino De Paoli; Fabio Matrone; Carlo Capirci; Giampaolo Montesi; Rita Marina Niespolo; Mattia Falchetto Osti; Luciana Caravatta; Alessandra Galardi; Domenico Genovesi; Maria Elena Rosetto; Caterina Boso; Piera Sciacero; Lucia Giaccherini; Salvatore Parisi; Antonella Fontana; Francesco Romeo Filippone; Vincenzo Picardi; Alessio Giuseppe Morganti; Vincenzo Valentini
Journal:  Clin Transl Radiat Oncol       Date:  2017-05-17

Review 6.  Controversial issues in radiotherapy for rectal cancer: a systematic review.

Authors:  Jong Hoon Kim
Journal:  Radiat Oncol J       Date:  2017-12-29

7.  Preoperative short course radiotherapy with concurrent and consolidation chemotherapies followed by delayed surgery in locally advanced rectal cancer: preliminary results.

Authors:  Mahdi Aghili; Sarvazad Sotoudeh; Reza Ghalehtaki; Mohammad Babaei; Borna Farazmand; Mohammad-Sadegh Fazeli; Amir Keshvari; Peiman Haddad; Farshid Farhan
Journal:  Radiat Oncol J       Date:  2018-03-30

8.  Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II-III resectable rectal cancer: a meta-analysis of randomized controlled trials.

Authors:  Jin Ho Song; Jae Uk Jeong; Jong Hoon Lee; Sung Hwan Kim; Hyeon Min Cho; Jun Won Um; Hong Seok Jang
Journal:  Radiat Oncol J       Date:  2017-09-15

9.  The Impact of Surgical Timing on Pathologic Tumor Response after Short Course and Long Course Preoperative Chemoradiation for Locally Advanced Rectal Adenocarcinoma.

Authors:  Sea-Won Lee; Jong Hoon Lee; In Kyu Lee; Seong Taek Oh; Dae Yong Kim; Tae Hyun Kim; Jae Hwan Oh; Ji Yeon Baek; Hee Jin Chang; Hee Chul Park; Hee Cheol Kim; Eui Kyu Chie; Taek-Keun Nam; Hong Seok Jang
Journal:  Cancer Res Treat       Date:  2017-11-21       Impact factor: 4.679

10.  Gastrointestinal Malignancies and the COVID-19 Pandemic: Evidence-Based Triage to Surgery.

Authors:  Scott C Fligor; Sophie Wang; Benjamin G Allar; Savas T Tsikis; Ana Sofia Ore; Ashlyn E Whitlock; Rodrigo Calvillo-Ortiz; Kevin R Arndt; Sidhu P Gangadharan; Mark P Callery
Journal:  J Gastrointest Surg       Date:  2020-06-30       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.